Today's Date: February 22, 2012

“We are executing a winning strategy that is focused on realizing the full potential of our pipeline and delivering the maximum benefit to our patients, their families and our shareholders”

--Kelly Martin, CEO

Senior Management

Kelly Martin, Chief Executive Officer
Nigel Clerkin, Chief Financial Officer
William F. Daniel, Company Secretary
Fabiana Lacerca-Allen, Chief Compliance Officer
Grainne McAleese, Group Controller and Principal Accounting Officer
John B. Moriarty Jr., JD, General Counsel
Grainne Quinn, MD, Chief Medical Officer

 
Kelly Martin, Chief Executive Officer

G. Kelly Martin was appointed a Director of Elan in February 2003, following his appointment as President and Chief Executive Officer. He was formerly a member of the executive management committee of Merrill Lynch & Co., Inc., where he spent more than 20 years in a broad array of operating responsibilities on a global basis.

Back to top
 
Nigel Clerkin, Chief Financial Officer

Nigel Clerkin was named Chief Financial Officer in May 2011. Prior to that, he had served as Senior Vice President, Finance and Group Controller since January 2004. He previously held a number of financial and strategic planning positions since joining Elan in January 1998. Mr. Clerkin is a chartered accountant and a graduate of Queen’s University Belfast.

Back to top
 
William F. Daniel, Company Secretary

William F. Daniel was appointed a Director of Elan in February 2003, and served until July 2007. He has served as the Company Secretary since December 2001, having joined Elan in March 1994 as Group Financial Controller. In July 1996, he was appointed Group Vice President, Finance, Group Controller and Principal Accounting Officer. From 1990 to 1992, Mr. Daniel was Financial Director of Xtravision, plc. Mr. Daniel is a chartered accountant and a graduate of University College Dublin.

Back to top
 
Fabiana Lacerca-Allen, Chief Compliance Officer

Fabiana Lacerca-Allen joined Elan as Senior Vice President, Chief Compliance Officer in June 2010. Lacerca-Allen has more than 18 years of compliance and legal experience at Fortune 500 companies and law firms in the U.S. and in Argentina. She joined Elan from Mylan Laboratories, where she was Senior Vice President and Chief Compliance Officer and led Mylan’s compliance programs, including the establishment of policies and compliance processes. Prior to her role with Mylan, Lacerca-Allen served as Legal Compliance Director for Bristol-Myers Squibb where she was a member of the executive team for Latin America, Canada and Puerto Rico and led all compliance initiatives in those regions. She has also held significant positions with Microsoft, Merck, Sharpe & Dohme (a subsidiary of Merck) and AT&T Capital.

Back to top
 
Grainne McAleese, Group Controller and Principal Accounting Officer

Grainne McAleese was appointed Group Controller and Principal Accounting Officer of Elan Corporation, plc, effective June 1, 2011. Since joining Elan in July 2004, Ms. McAleese has worked in a number of roles in the Group Finance area. Prior to joining Elan, she worked with PricewaterhouseCoopers in New York and previously KPMG in Dublin. Ms. McAleese is a Certified Public Accountant in the United States, a Fellow of Chartered Accountants Ireland and a graduate of Dublin City University.

Back to top
 
John B. Moriarty Jr., JD, General Counsel

John B. Moriarty Jr. was named General Counsel in March 2010. Mr. Moriarty joined Elan in December 2008 as Senior Vice President, Legal - Commercial Operations & Litigation. Prior to joining Elan, Mr. Moriarty worked at Amgen, where he served as Executive Director and Associate General Counsel, Global Commercial Operations, and was Amgen's Senior Counsel, Complex Litigation, Products Liability and Government Investigations. Before working at Amgen, Mr. Moriarty was in private practice with a national law firm where his areas of expertise included reimbursement (Medicare, Medicaid and third-party payment programs), federal and state government investigations and proceedings, and corporate internal investigations. Earlier in his career, he was a healthcare fraud prosecutor in the Virginia Office of the Attorney General and also served for two years as a Special Assistant United States Attorney for healthcare fraud. Mr. Moriarty graduated from the University of Virginia, with distinction, and the University of Georgia School of Law, cum laude.

Back to top
 
Grainne Quinn, MD, Chief Medical Officer

Grainne Quinn, MD, was appointed Chief Medical Officer in October 2011. She was named Vice President for the Global Pharmacovigilance and Risk Management (GPRM) group, which she continues to manage, in April 2010. Prior to joining Elan in January 2009, Dr. Quinn spent seven years at Quintiles Ireland Ltd., where she held several leadership positions, including Executive Director, Medical and Scientific Services, Global Head of Safety Physicians. In addition, she has practiced as an internist in Boston, Massachusetts, and Minneapolis, Minnesota. Dr. Quinn earned her medical degree from the Royal College of Surgeons in Ireland, and received her board certification in internal medicine in 1995 from the American Board of Internal Medicine.

Back to top